United States RNA-based Biopharmaceuticals Market Report 2018

Table of Contents

United States RNA-based Biopharmaceuticals Market Report 2018
1 RNA-based Biopharmaceuticals Overview
1.1 Product Overview and Scope of RNA-based Biopharmaceuticals
1.2 Classification of RNA-based Biopharmaceuticals by Product Category
1.2.1 United States RNA-based Biopharmaceuticals Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States RNA-based Biopharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Therapeutics
1.2.4 Vaccines
1.3 United States RNA-based Biopharmaceuticals Market by Application/End Users
1.3.1 United States RNA-based Biopharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 United States RNA-based Biopharmaceuticals Market by Region
1.4.1 United States RNA-based Biopharmaceuticals Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West RNA-based Biopharmaceuticals Status and Prospect (2013-2025)
1.4.3 Southwest RNA-based Biopharmaceuticals Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic RNA-based Biopharmaceuticals Status and Prospect (2013-2025)
1.4.5 New England RNA-based Biopharmaceuticals Status and Prospect (2013-2025)
1.4.6 The South RNA-based Biopharmaceuticals Status and Prospect (2013-2025)
1.4.7 The Midwest RNA-based Biopharmaceuticals Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of RNA-based Biopharmaceuticals (2013-2025)
1.5.1 United States RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2025)
1.5.2 United States RNA-based Biopharmaceuticals Revenue and Growth Rate (2013-2025)

2 United States RNA-based Biopharmaceuticals Market Competition by Players/Suppliers
2.1 United States RNA-based Biopharmaceuticals Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States RNA-based Biopharmaceuticals Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States RNA-based Biopharmaceuticals Average Price by Players/Suppliers (2013-2018)
2.4 United States RNA-based Biopharmaceuticals Market Competitive Situation and Trends
2.4.1 United States RNA-based Biopharmaceuticals Market Concentration Rate
2.4.2 United States RNA-based Biopharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers RNA-based Biopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type

3 United States RNA-based Biopharmaceuticals Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States RNA-based Biopharmaceuticals Sales and Market Share by Region (2013-2018)
3.2 United States RNA-based Biopharmaceuticals Revenue and Market Share by Region (2013-2018)
3.3 United States RNA-based Biopharmaceuticals Price by Region (2013-2018)

4 United States RNA-based Biopharmaceuticals Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States RNA-based Biopharmaceuticals Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States RNA-based Biopharmaceuticals Revenue and Market Share by Type (2013-2018)
4.3 United States RNA-based Biopharmaceuticals Price by Type (2013-2018)
4.4 United States RNA-based Biopharmaceuticals Sales Growth Rate by Type (2013-2018)

5 United States RNA-based Biopharmaceuticals Sales (Volume) by Application (2013-2018)
5.1 United States RNA-based Biopharmaceuticals Sales and Market Share by Application (2013-2018)
5.2 United States RNA-based Biopharmaceuticals Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States RNA-based Biopharmaceuticals Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Roche
6.2.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Sanofi-Aventis
6.3.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Abbott Laboratories
6.4.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Arrowhead Pharmaceuticals
6.5.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Benitec Biopharma
6.6.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Calimmune Inc
6.7.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Dicerna
6.8.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Gradalis
6.9.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Quark
6.10.2 RNA-based Biopharmaceuticals Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 RXi
6.12 Senesco
6.13 Silence Therapeutics
6.14 Silenseed
6.15 Tekmira
6.16 Alnylam Pharmaceuticals

7 RNA-based Biopharmaceuticals Manufacturing Cost Analysis
7.1 RNA-based Biopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 RNA-based Biopharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of RNA-based Biopharmaceuticals Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States RNA-based Biopharmaceuticals Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States RNA-based Biopharmaceuticals Sales Volume, Revenue Forecast (2018-2025)
11.2 United States RNA-based Biopharmaceuticals Sales Volume Forecast by Type (2018-2025)
11.3 United States RNA-based Biopharmaceuticals Sales Volume Forecast by Application (2018-2025)
11.4 United States RNA-based Biopharmaceuticals Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of RNA-based Biopharmaceuticals
Figure United States RNA-based Biopharmaceuticals Market Size (K Units) by Type (2013-2025)
Figure United States RNA-based Biopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2017
Figure Therapeutics Product Picture
Figure Vaccines Product Picture
Figure United States RNA-based Biopharmaceuticals Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of RNA-based Biopharmaceuticals by Application in 2017
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States RNA-based Biopharmaceuticals Market Size (Million USD) by Region (2013-2025)
Figure The West RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2025)
Figure United States RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States RNA-based Biopharmaceuticals Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States RNA-based Biopharmaceuticals Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States RNA-based Biopharmaceuticals Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States RNA-based Biopharmaceuticals Sales Share by Players/Suppliers
Figure 2017 United States RNA-based Biopharmaceuticals Sales Share by Players/Suppliers
Figure United States RNA-based Biopharmaceuticals Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States RNA-based Biopharmaceuticals Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States RNA-based Biopharmaceuticals Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States RNA-based Biopharmaceuticals Revenue Share by Players/Suppliers
Figure 2017 United States RNA-based Biopharmaceuticals Revenue Share by Players/Suppliers
Table United States Market RNA-based Biopharmaceuticals Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market RNA-based Biopharmaceuticals Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States RNA-based Biopharmaceuticals Market Share of Top 3 Players/Suppliers
Figure United States RNA-based Biopharmaceuticals Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers RNA-based Biopharmaceuticals Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers RNA-based Biopharmaceuticals Product Category
Table United States RNA-based Biopharmaceuticals Sales (K Units) by Region (2013-2018)
Table United States RNA-based Biopharmaceuticals Sales Share by Region (2013-2018)
Figure United States RNA-based Biopharmaceuticals Sales Share by Region (2013-2018)
Figure United States RNA-based Biopharmaceuticals Sales Market Share by Region in 2017
Table United States RNA-based Biopharmaceuticals Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States RNA-based Biopharmaceuticals Revenue Share by Region (2013-2018)
Figure United States RNA-based Biopharmaceuticals Revenue Market Share by Region (2013-2018)
Figure United States RNA-based Biopharmaceuticals Revenue Market Share by Region in 2017
Table United States RNA-based Biopharmaceuticals Price (USD/Unit) by Region (2013-2018)
Table United States RNA-based Biopharmaceuticals Sales (K Units) by Type (2013-2018)
Table United States RNA-based Biopharmaceuticals Sales Share by Type (2013-2018)
Figure United States RNA-based Biopharmaceuticals Sales Share by Type (2013-2018)
Figure United States RNA-based Biopharmaceuticals Sales Market Share by Type in 2017
Table United States RNA-based Biopharmaceuticals Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States RNA-based Biopharmaceuticals Revenue Share by Type (2013-2018)
Figure Revenue Market Share of RNA-based Biopharmaceuticals by Type (2013-2018)
Figure Revenue Market Share of RNA-based Biopharmaceuticals by Type in 2017
Table United States RNA-based Biopharmaceuticals Price (USD/Unit) by Types (2013-2018)
Figure United States RNA-based Biopharmaceuticals Sales Growth Rate by Type (2013-2018)
Table United States RNA-based Biopharmaceuticals Sales (K Units) by Application (2013-2018)
Table United States RNA-based Biopharmaceuticals Sales Market Share by Application (2013-2018)
Figure United States RNA-based Biopharmaceuticals Sales Market Share by Application (2013-2018)
Figure United States RNA-based Biopharmaceuticals Sales Market Share by Application in 2017
Table United States RNA-based Biopharmaceuticals Sales Growth Rate by Application (2013-2018)
Figure United States RNA-based Biopharmaceuticals Sales Growth Rate by Application (2013-2018)
Table Pfizer Basic Information List
Table Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer RNA-based Biopharmaceuticals Sales Growth Rate (2013-2018)
Figure Pfizer RNA-based Biopharmaceuticals Sales Market Share in United States (2013-2018)
Figure Pfizer RNA-based Biopharmaceuticals Revenue Market Share in United States (2013-2018)
Table Roche Basic Information List
Table Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche RNA-based Biopharmaceuticals Sales Growth Rate (2013-2018)
Figure Roche RNA-based Biopharmaceuticals Sales Market Share in United States (2013-2018)
Figure Roche RNA-based Biopharmaceuticals Revenue Market Share in United States (2013-2018)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi-Aventis RNA-based Biopharmaceuticals Sales Growth Rate (2013-2018)
Figure Sanofi-Aventis RNA-based Biopharmaceuticals Sales Market Share in United States (2013-2018)
Figure Sanofi-Aventis RNA-based Biopharmaceuticals Revenue Market Share in United States (2013-2018)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Laboratories RNA-based Biopharmaceuticals Sales Growth Rate (2013-2018)
Figure Abbott Laboratories RNA-based Biopharmaceuticals Sales Market Share in United States (2013-2018)
Figure Abbott Laboratories RNA-based Biopharmaceuticals Revenue Market Share in United States (2013-2018)
Table Arrowhead Pharmaceuticals Basic Information List
Table Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales Growth Rate (2013-2018)
Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales Market Share in United States (2013-2018)
Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Revenue Market Share in United States (2013-2018)
Table Benitec Biopharma Basic Information List
Table Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Benitec Biopharma RNA-based Biopharmaceuticals Sales Growth Rate (2013-2018)
Figure Benitec Biopharma RNA-based Biopharmaceuticals Sales Market Share in United States (2013-2018)
Figure Benitec Biopharma RNA-based Biopharmaceuticals Revenue Market Share in United States (2013-2018)
Table Calimmune Inc Basic Information List
Table Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Calimmune Inc RNA-based Biopharmaceuticals Sales Growth Rate (2013-2018)
Figure Calimmune Inc RNA-based Biopharmaceuticals Sales Market Share in United States (2013-2018)
Figure Calimmune Inc RNA-based Biopharmaceuticals Revenue Market Share in United States (2013-2018)
Table Dicerna Basic Information List
Table Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dicerna RNA-based Biopharmaceuticals Sales Growth Rate (2013-2018)
Figure Dicerna RNA-based Biopharmaceuticals Sales Market Share in United States (2013-2018)
Figure Dicerna RNA-based Biopharmaceuticals Revenue Market Share in United States (2013-2018)
Table Gradalis Basic Information List
Table Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Gradalis RNA-based Biopharmaceuticals Sales Growth Rate (2013-2018)
Figure Gradalis RNA-based Biopharmaceuticals Sales Market Share in United States (2013-2018)
Figure Gradalis RNA-based Biopharmaceuticals Revenue Market Share in United States (2013-2018)
Table Quark Basic Information List
Table Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Quark RNA-based Biopharmaceuticals Sales Growth Rate (2013-2018)
Figure Quark RNA-based Biopharmaceuticals Sales Market Share in United States (2013-2018)
Figure Quark RNA-based Biopharmaceuticals Revenue Market Share in United States (2013-2018)
Table RXi Basic Information List
Table Senesco Basic Information List
Table Silence Therapeutics Basic Information List
Table Silenseed Basic Information List
Table Tekmira Basic Information List
Table Alnylam Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA-based Biopharmaceuticals
Figure Manufacturing Process Analysis of RNA-based Biopharmaceuticals
Figure RNA-based Biopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of RNA-based Biopharmaceuticals Major Players/Suppliers in 2017
Table Major Buyers of RNA-based Biopharmaceuticals
Table Distributors/Traders List
Figure United States RNA-based Biopharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States RNA-based Biopharmaceuticals Price (USD/Unit) Trend Forecast (2018-2025)
Table United States RNA-based Biopharmaceuticals Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States RNA-based Biopharmaceuticals Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States RNA-based Biopharmaceuticals Sales Volume (K Units) Forecast by Type in 2025
Table United States RNA-based Biopharmaceuticals Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States RNA-based Biopharmaceuticals Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States RNA-based Biopharmaceuticals Sales Volume (K Units) Forecast by Application in 2025
Table United States RNA-based Biopharmaceuticals Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States RNA-based Biopharmaceuticals Sales Volume Share Forecast by Region (2018-2025)
Figure United States RNA-based Biopharmaceuticals Sales Volume Share Forecast by Region (2018-2025)
Figure United States RNA-based Biopharmaceuticals Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.